Transparent pricing Membership-free US-sourced ingredients Unlimited 24/7 support 100% online State-licensed pharmacies Clinician-led care

Our partner pharmacies have served 100,000+ patients

$229/month

Compounded · GLP-1 Care for Perimenopause

Tirzepatide Injection

Our partner pharmacies
have served 100,000+ patients

For perimenopause and menopause weight gain that
feels different after 40.

See if I qualify

No charge today Takes about 3 minutes

  • Licensed medical providers
  • State-licensed pharmacies
  • Same-day prescriptions
  • 2-day shipping
Compounded tirzepatide injection — online telehealth care from Cypress Health
  • 2-day shipping · direct-to-door
  • Cancel anytime before your next ship date
  • Includes clinician oversight, dose escalation, and side-effect support
Your care
Clinician-ledCare
State-LicensedCompounding Pharmacies
HIPAACompliant
Available inAll 50 US states

How it works

Simple online
telehealth care, built around you.

Start your assessment

3-minute screener · No commitment

1
Complete your intake
Tell us about your health history, goals, symptoms, and what's changed. This takes less than 3 minutes.
Start Now
2
Get provider review
A licensed U.S. provider reviews your information and determines whether treatment is appropriate — typically within 24 hours.
Learn More
3
Start your plan
If eligible, your plan may include compounded GLP-1 medication with pharmacy coordination, ongoing oversight, and direct-to-door delivery.

Our physician partner

Medical oversight by Arora Health

Your care is reviewed and overseen by board-certified, U.S.-licensed physicians at Arora Health & Aesthetics — our independent medical partner, with clinician coverage in all 50 states.

Dr. Sean Arora, Co-Founder and CEO of Arora Health & Aesthetics

Dr. Sean Arora

Arora Co-Founder & CEO

  • Board-certified physician
  • Licensed in all 50 states

Dr. Sean Arora is a board-certified physician and the founder of Arora Health & Aesthetics, bringing deep expertise in wellness, family medicine, and telehealth innovation.

He leads one of the nation's most comprehensive medical oversight and compliance networks, supporting clinics through full-spectrum medical directorship, nationwide telehealth provider coverage, and evidence-based protocol development across peptides, hormone optimization, weight loss, regenerative medicine, and aesthetic treatments.

Known for his forward-thinking approach to patient safety and scalable clinical operations, Dr. Arora partners closely with medical spas, wellness clinics, and telehealth organizations to ensure responsible, compliant, and impactful care. Licensed in all 50 states, he is dedicated to expanding access to high-quality wellness services through innovation, leadership, and patient-centered standards.

Dr. Shannon Arora, Chief Medical Officer of Arora Health & Aesthetics

Dr. Shannon Arora

Chief Medical Officer

  • Hospital-trained physician
  • Preventive & longevity medicine

Dr. Shannon Arora is a physician dedicated to making a meaningful impact on patient health through both traditional medicine and proactive wellness care.

With experience as a hospitalist, she brings a strong clinical foundation shaped by work in hospitals and nursing homes, offering a broad perspective on patient care across diverse settings. While her early career focused on acute care, Dr. Arora recognized an opportunity to create a more proactive, personalized approach within the health, wellness, and longevity space. She now focuses on optimizing patient health through advanced wellness therapies, preventative medicine, and longevity-focused care, helping patients improve energy, confidence, and overall quality of life.

As Chief Medical Officer, Dr. Arora is passionate about advancing innovation in regenerative medicine and wellness, while helping both patients and organizations achieve better outcomes through thoughtful, patient-centered care.

Why tirzepatide

Two receptors. One injection. A different conversation.

Compounded tirzepatide injection for perimenopause weight loss

Tirzepatide is a prescription medication, not a supplement. Cypress offers compounded tirzepatide by online prescription — reviewed by a licensed U.S. provider who determines whether it’s appropriate for you.

Semaglutide acts on the GLP-1 receptor — one of two pathways involved in regulating appetite, satiety, and metabolism. Tirzepatide acts on both GLP-1 and GIP. The dual mechanism is delivered with the same once-weekly cadence.

For some women in midlife, the dual mechanism may be a fit when other approaches haven't been a match. Whether that's true for you isn't something we can promise — only your clinician can determine appropriateness, based on your medical history, current medications, and goals.

The intake is the first step. Outcomes vary; tirzepatide is not appropriate for everyone.

Dosing

A measured start. Adjusted as you go.

1
Weeks 1–4 · Starting dose
2.5 mg once weekly. Most patients tolerate this well; mild GI symptoms are common in the first week or two and typically settle.
2
Weeks 5+ · Dose escalation
Your clinician adjusts your dose based on response and tolerance — typically 5 mg, 7.5 mg, 10 mg, with options up to 15 mg as appropriate.
3
Ongoing · Care, not just refills
Your plan includes ongoing clinician oversight, dose adjustment, side-effect support, and lab review when needed. We don't disappear after the first ship.

Side effects & safety

What to know before you start.

Woman in midlife smiling, considering her tirzepatide care plan

Most common: nausea, decreased appetite, mild diarrhea, constipation, fatigue. These are typically dose-related and most pronounced in the first week of each new dose.

Less common but important: pancreatitis, gallbladder issues, low blood sugar (especially if you also take insulin or sulfonylureas). Tell your clinician about all current medications.

Muscle mass during treatment: GLP-1 therapy can be associated with loss of lean mass, particularly in women in midlife. Your clinician will discuss strategies to protect muscle — typically resistance training and adequate dietary protein — as part of your care plan.

Not appropriate if: you have a personal or family history of medullary thyroid carcinoma or MEN2; you're pregnant, planning pregnancy, or breastfeeding; or you have severe GI disease or end-stage organ disease.

Questions

Answers to
common questions.

How is compounded tirzepatide prepared?
Compounded by a licensed 503A pharmacy on a per-patient basis.
Compounded tirzepatide is prepared by a state-licensed U.S. pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act. Each preparation is dispensed per-patient based on a licensed clinician's prescription. Compounded preparations are not interchangeable with branded medications and may differ in formulation, strength, and clinical profile. Your clinician will help determine whether compounded tirzepatide is appropriate for your specific health profile.
How does tirzepatide compare to semaglutide?
Dual GLP-1/GIP mechanism — greater average weight loss in published trials.
Tirzepatide acts on two appetite-regulating hormone pathways — GLP-1 and GIP — while semaglutide acts on GLP-1 alone. The dual mechanism translated to greater average weight loss in published trials. SURMOUNT-1 (Jastreboff et al., NEJM 2022) showed up to ~20.9% body weight loss at the 15 mg weekly dose over 72 weeks. For women who've plateaued on semaglutide or who are starting GLP-1 therapy later in life, tirzepatide is often considered. Outcomes from branded clinical trials cannot be directly attributed to compounded preparations.
When am I charged?
Not until a clinician confirms your eligibility — typically within 24–48 hours.
You're not charged when you submit. Your card is securely saved while a licensed clinician reviews your assessment, typically within 24 to 48 hours. If approved, you'll receive an email confirmation before any charge. If not approved, you're not charged.
Will I need to stay on treatment after I reach my goal?
Most people regain weight without a structured maintenance plan. We plan that step with you.
The available evidence shows most people regain weight when GLP-1 or GLP-1/GIP therapy stops without a structured maintenance plan; the SURMOUNT-4 withdrawal trial (Aronne et al., JAMA 2024) showed weight regain after tirzepatide was discontinued. Options include stepping down to a lower maintenance dose, weaning off with structured resistance training and protein-forward eating to protect lean mass, or continuing at full dose. The right path is decided with you when the time comes — not around you.
Can I cancel?
Cancel anytime before your next ship date.
Your monthly subscription can be cancelled anytime before your next ship date — there's no long-term commitment. Medication, supplies, and shipping are all included while you're active.
Is insurance required?
No — transparent flat-rate pricing, no hidden fees.
No. Cypress offers transparent, flat-rate pricing without insurance and no hidden fees. Medication, supplies, and shipping are all included.
Can I use my FSA/HSA?
Yes — itemized receipts provided for self-submission.
Yes. HSA and FSA cards are accepted on any plan. We also provide itemized receipts in case you need to self-submit to your benefits provider.

See if tirzepatide is right for you.

The 3-minute medical screener is free. If you're a candidate, your clinician typically follows up within 24 hours.

See if I qualify
No charge today See if I qualify